tradingkey.logo
tradingkey.logo
Search

Cytosorbents Corp

CTSO
Add to Watchlist
5.750USD
-0.010-0.17%
Close 09-18 16:00ET
18.54MMarket Cap
LossP/E TTM

CTSO Financials

See Cytosorbents Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
18.54M
Dividend TTM
0.00
P/E TTM
-31.19
EPS TTM
-0.19
Revenue
37.06M
Net Profit
-20.72M
ROE
-141.59%
ROA
-25.94%

Cytosorbents Corp Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.07/-0.05
Revenue / Forecast
9.63M/9.35M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-326.14%-1.41
-235.87%-1.64
95.43%-0.13
0.63%-1.01
139.33%0.62
78.24%-0.49
-2.03%-2.88
-390.68%-1.02
-1031.27%-1.58
-1233.69%-2.24
-15984.28%-2.82
---0.21
---0.14
---0.17
---0.02
---0.74
----
----
----
----
Revenue
0.17%9.63M
1.57%8.86M
41.56%9.23M
1.01%9.48M
-2.81%9.62M
-2.92%8.73M
91.65%6.52M
6.58%9.39M
5.03%9.89M
-4.87%8.99M
-63.75%3.40M
8.62%8.81M
10.89%9.42M
8.72%9.45M
-12.91%9.39M
-16.90%8.11M
-29.35%8.50M
-18.00%8.69M
-9.82%10.78M
-7.45%9.76M
Net Profit
-326.86%-4.42M
-246.94%-5.13M
30.28%-5.50M
-35.81%-3.17M
146.99%1.95M
75.72%-1.48M
-19.92%-7.88M
74.61%-2.33M
32.67%-4.14M
16.89%-6.09M
-758.12%-6.57M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
91.77%-766.13K
-90.45%-12.20M
-132.58%-10.88M
-115.13%-8.97M
-1273.27%-9.31M
-662.90%-6.41M
Net Margin
-326.49%-45.85%
-241.59%-57.86%
81.70%-22.12%
-3.99%-33.42%
141.69%20.25%
74.99%-16.94%
37.43%-120.86%
69.20%-32.14%
25.65%-48.56%
12.64%-67.73%
-2267.41%-193.15%
---104.34%
---65.31%
---77.53%
---8.16%
---126.67%
----
----
----
----
Gross Margin
3.28%73.18%
-2.77%69.16%
-31.14%71.48%
15.17%70.28%
-3.66%70.85%
-6.98%71.13%
-27.49%103.80%
-4.10%61.02%
15.12%73.55%
32.45%76.46%
133.49%143.15%
--63.64%
--63.89%
--57.73%
--61.31%
--59.20%
----
----
----
----
Debt to assets ratio
51.61%45.42%
49.66%41.81%
27.68%37.72%
10.25%31.84%
17.06%29.96%
196.93%27.94%
210.27%29.55%
173.04%28.88%
167.29%25.59%
7.90%9.41%
20.43%9.52%
--10.58%
--9.57%
--8.72%
--7.91%
----
----
----
----
----
Revenue
0.17%9.63M
1.57%8.86M
41.56%9.23M
1.01%9.48M
-2.81%9.62M
-2.92%8.73M
91.65%6.52M
6.58%9.39M
5.03%9.89M
-4.87%8.99M
-63.75%3.40M
8.62%8.81M
10.89%9.42M
8.72%9.45M
-12.91%9.39M
-16.90%8.11M
-29.35%8.50M
-18.00%8.69M
-9.82%10.78M
-7.45%9.76M
Operating profit
34.50%-2.37M
21.69%-3.04M
13.66%-3.48M
38.55%-2.66M
-11.79%-3.62M
16.52%-3.89M
59.35%-4.02M
39.55%-4.33M
50.54%-3.23M
40.15%-4.66M
-79.52%-9.90M
20.52%-7.17M
20.57%-6.54M
-3.95%-7.78M
42.32%-5.52M
-66.80%-9.02M
-67.14%-8.23M
-162.43%-7.49M
-262.98%-9.56M
-175.87%-5.41M
Net Profit
-326.86%-4.42M
-246.94%-5.13M
30.28%-5.50M
-35.81%-3.17M
146.99%1.95M
75.72%-1.48M
-19.92%-7.88M
74.61%-2.33M
32.67%-4.14M
16.89%-6.09M
-758.12%-6.57M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
91.77%-766.13K
-90.45%-12.20M
-132.58%-10.88M
-115.13%-8.97M
-1273.27%-9.31M
-662.90%-6.41M
Current assets
-31.54%15.74M
-30.13%17.76M
-4.49%20.63M
28.41%21.31M
4.70%22.99M
27.11%25.41M
-14.94%21.60M
-13.83%16.60M
-7.14%21.96M
-29.02%19.99M
-24.77%25.40M
-40.52%19.26M
-43.23%23.64M
-49.57%28.16M
-47.50%33.76M
-55.49%32.38M
-45.97%41.65M
-29.86%55.85M
-22.02%64.30M
-24.85%72.75M
Total current liabilities
144.09%24.02M
67.45%16.30M
-1.17%9.71M
19.95%10.11M
-4.78%9.84M
-27.47%9.74M
-30.00%9.82M
-29.59%8.43M
-0.14%10.34M
28.63%13.42M
44.48%14.04M
18.32%11.97M
-1.92%10.35M
-28.87%10.44M
-29.04%9.71M
-8.60%10.12M
-2.24%10.55M
50.34%14.67M
34.84%13.69M
-36.22%11.07M
Total assets
-20.90%37.96M
-20.12%40.56M
-6.73%44.18M
-4.30%45.75M
-10.18%47.99M
7.88%50.78M
-10.55%47.37M
0.48%47.80M
1.87%53.43M
-18.09%47.07M
-16.25%52.96M
-23.60%47.58M
-26.35%52.44M
-30.99%57.46M
-29.37%63.23M
-34.50%62.27M
-27.48%71.21M
-4.81%83.27M
-0.48%89.52M
-8.84%95.07M
Total liabilities
6.34%38.71M
5.88%38.37M
5.55%38.28M
5.53%36.73M
-0.78%36.40M
28.77%36.24M
23.03%36.26M
19.76%34.80M
29.42%36.69M
-1.28%28.14M
5.81%29.48M
25.66%29.06M
19.90%28.35M
2.38%28.51M
3.40%27.86M
-5.43%23.13M
-0.68%23.65M
172.44%27.84M
150.97%26.94M
1.69%24.46M
Total equity
-106.48%-751.00K
-84.91%2.19M
-46.85%5.90M
-30.61%9.02M
-30.77%11.59M
-23.17%14.54M
-52.70%11.11M
-29.78%13.00M
-30.54%16.74M
-34.63%18.93M
-33.62%23.48M
-52.71%18.51M
-49.34%24.09M
-47.76%28.96M
-43.47%35.37M
-44.57%39.14M
-36.06%47.56M
-28.26%55.43M
-21.00%62.58M
-11.99%70.61M
Net operating income
61.39%-583.00K
66.46%-1.16M
-106.01%-4.83M
-4.70%-2.58M
68.51%-1.51M
28.26%-3.46M
63.45%-2.34M
52.73%-2.46M
30.85%-4.79M
-55.39%-4.83M
-19.98%-6.41M
22.70%-5.21M
13.77%-6.93M
61.72%-3.11M
2.75%-5.34M
-62.93%-6.73M
-294.84%-8.04M
-246.35%-8.12M
-419.15%-5.49M
-25.86%-4.13M
Net investment
105.31%7.00K
2.63%-46.00K
-134.31%-291.00K
118.43%55.00K
-9.92%-131.76K
62.81%-47.24K
8.63%-124.19K
-15.77%-298.35K
-185.44%-119.86K
81.40%-127.02K
34.04%-135.92K
64.03%-257.72K
102.99%140.28K
19.47%-682.88K
87.68%-206.08K
29.58%-716.53K
-375.79%-4.69M
-39.85%-847.96K
-528.53%-1.67M
-151.75%-1.02M
Net financing
100.00%0.00
-100.00%0.00
1385.08%2.48M
100.00%0.00
-100.01%-1.13K
1294.93%6.83M
-98.63%166.86K
-115.27%-99.03K
956.22%9.83M
-183.56%-571.76K
144.21%12.21M
--648.32K
--931.12K
1795.49%684.28K
6278.64%5.00M
-100.00%0.00
-100.00%0.00
-152.72%-40.36K
99.47%-80.92K
-98.95%589.72K

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its total revenue reached 37.06M, with a year-on-year change of 35.59M.

What are the current assets of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its current assets were 20.63M, with a year-on-year change of -4.49.

What are the total assets of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its total assets of Cytosorbents Corp were 44.18M, with a year-on-year change of -6.73.

What are the total liabilities of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its total liabilities of Cytosorbents Corp were 38.28M, with a year-on-year change of 5.55.

What is the total equity of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its total equity of Cytosorbents Corp was 5.90M, with a year-on-year change of -46.85.

What is the net operating income of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net operating income of Cytosorbents Corp was -13.64M, with a year-on-year change of 17.10.

What is the net investment of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net investment of Cytosorbents Corp was -415.00K, with a year-on-year change of 38.01.

What is the net financing of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net financing of Cytosorbents Corp was 9.31M, with a year-on-year change of -0.23.

What is the Earnings Per Share (EPS) of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -2.63, with a year-on-year change of 65.39.

What is the net income of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net income was -8.20M, with a year-on-year change of 60.43.

What is the net margin of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its net profit margin was -22.12, with a year-on-year change of 62.00.

What is the gross margin of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its gross margin was 71.48, with a year-on-year change of 1.26.

What is the debt-to-asset ratio of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its debt-to-asset ratio was 37.72, with a year-on-year change of 27.68.

What is the Return on Equity (ROE) of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its Return on Equity (ROE) was -96.39, with a year-on-year change of 19.54.

What is the Return on Assets (ROA) of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its Return on Assets (ROA) was -17.91, with a year-on-year change of 56.64.

What is the operating profit of Cytosorbents Corp?

According to Cytosorbents Corp's FY2025 earnings report, its operating profit was -13.64M, with a year-on-year change of 17.10.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.